Embark Ventures reposted this
Embark Ventures portfolio company CellFE just launched the T-Rest, a groundbreaking tool to improve the efficiency and viability of CAR-T cell therapy manufacturing. Better cell engineering = more effective therapies, broader access, and faster timelines for patients who need them most. #celltherapy #Biotech
🌟 Exciting News from CellFE! 🌟 We’ve just announced the launch of T-Rest, our first-in-class transfection media kit designed specifically for resting (quiescent) T cell workflows. This breakthrough product offers a paradigm shift for cell therapy manufacturers to develop safer and more potent therapies compared to traditional workflows. ➡️ Stop by our booth #752 at Advanced Therapies Week (ATW) 2025 in Dallas, January 20–23 to see T-Rest in action and learn more about our optimized CAR-T workflows. ➡️ To read the full press release and access our application note on the non-viral, non-electroporative resting T cell workflow, visit: https://lnkd.in/eji_msk2 We’re thrilled to help shape the future of cell therapy manufacturing—together, let’s make these lifesaving treatments more accessible to patients everywhere! #TRest #NonViral #NonElectroporative #GeneEditing #ATW2025 #CellTherapy #Biotech #HealthcareInnovation